Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02275325
Other study ID # 2014-A01189-38
Secondary ID 140989B-31
Status Recruiting
Phase N/A
First received October 17, 2014
Last updated June 20, 2016
Start date January 2015
Est. completion date April 2019

Study information

Verified date June 2016
Source Central Hospital, Nancy, France
Contact Cécile Parietti-Winkler, MD, PhD
Phone +33 383 852 032
Email c.parietti@chu-nancy.fr
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

Vestibular schwannoma (VS) is a benign tumour from Schwann cells surrounding the vestibular nerve, which slowly grows within the internal auditory canal and then into the cerebellopontine angle, leading to a gradual vestibular dysfunction. The slowly progressive alteration of vestibular function allows the gradual implementation of central adaptive mechanisms called vestibular compensation. The total unilateral vestibular deafferentation induced by the surgical tumour removal suddenly leads to a decompensation of this previously compensated situation, which explains why most patients report severe vertigo immediately after surgery and which is responsible for perturbations of the postural control (Parietti-Winkler et al., 2006, 2008, 2010, 2011). Recently, Gauchard et al. (2013) suggested that preoperative and regular physical activity would limit the adverse effects of surgical removal on balance control. Also, patients benefited faster and better from the postoperative vestibular rehabilitation.

Thus, preoperative vestibular rehabilitation, including physical and balance exercises, could help to limit postoperative balance disorders and promote postoperative balance compensation. This could lead to a decrease in the duration and cost of the postoperative management and faster improvement of quality of life.


Description:

To test this hypothesis, the measured and perceived balance control of the patient and the quality of life will be assessed into two groups: one of two groups will receive preoperative vestibular rehabilitation, carried out by a physiotherapist, and the other not. The assessments will be conducted 45 days and 3 days before surgery, and then 8 days, 30 days, 90 days and 365 days after surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date April 2019
Est. primary completion date April 2018
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Patients with unilateral vestibular schwannoma (stage I to IV according to the Koos classification) with an indication for surgery.

- Patients gave their written informed consent

- Patients are affiliated to the french social welfare

Exclusion Criteria:

- Disorders from the motor and/or somesthetic systems (especially the lower limbs)

- Contraindications to the scheduled functional assessments: ear pathology different from vestibular schwannoma such as cholesteatoma of the middle ear, tympanic membrane perforation, etc.

- Refusal of the surgical procedure

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Preoperative vestibular rehabilitation
12 one-hour sessions with exercises of balance on unstable conditions (foam, tilt of the platform, biofeedback)

Locations

Country Name City State
France University Hospital of Nancy Nancy

Sponsors (2)

Lead Sponsor Collaborator
Central Hospital, Nancy, France University of Lorraine

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Acute balance compensation Change in composite equilibrium score from baseline to 8 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and the composite equilibrium (in %) score is calculated over the six conditions of the Sensory Organization Test (Equitest, Neurocom, USA).
Comparison between both groups (preoperative rehabilitation vs. usual).
One week after surgery No
Secondary Balance compensation at short term Change in composite equilibrium score from baseline to 30 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and the composite equilibrium (in %) score is calculated over the six conditions of the Sensory Organization Test (Equitest, Neurocom, USA).
Comparison between both groups (preoperative rehabilitation vs. usual).
One month after surgery No
Secondary Balance compensation at middle term Change in composite equilibrium score from baseline to 90 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and the composite equilibrium (in %) score is calculated over the six conditions of the Sensory Organization Test (Equitest, Neurocom, USA).
Comparison between both groups (preoperative rehabilitation vs. usual).
Three months after surgery No
Secondary Balance compensation at long term Change in composite equilibrium score from baseline to 365 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and the composite equilibrium (in %) score is calculated over the six conditions of the Sensory Organization Test (Equitest, Neurocom, USA).
Comparison between both groups (preoperative rehabilitation vs. usual).
One year after surgery No
Secondary Preoperative balance compensation Change in composite equilibrium score from baseline to three days before surgery. The baseline corresponds to the day before the preoperative rehabilitation and the composite equilibrium (in %) score is calculated over the six conditions of the Sensory Organization Test (Equitest, Neurocom, USA).
Comparison between both groups (preoperative rehabilitation vs. usual).
From baseline to three days before surgery No
Secondary Acute change in self-rated dizziness (measured with the Dizziness Handicap Inventory) Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) from baseline to 8 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation.
Comparison between both groups (preoperative rehabilitation vs. usual).
One week after surgery No
Secondary Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) at short term Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) from baseline to 30 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation.
Comparison between both groups (preoperative rehabilitation vs. usual).
One month after surgery No
Secondary Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) at middle term Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) from baseline to 90 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation.
Comparison between both groups (preoperative rehabilitation vs. usual).
Three months after surgery No
Secondary Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) at long term Change in self-rated dizziness (measured with the Dizziness Handicap Inventory) from baseline to 365 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation.
Comparison between both groups (preoperative rehabilitation vs. usual).
One year after surgery No
Secondary Acute change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) from baseline to 8 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation.
Comparison between both groups (preoperative rehabilitation vs. usual).
One week after surgery No
Secondary Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) at short term Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) from baseline to 30 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation.
Comparison between both groups (preoperative rehabilitation vs. usual).
One month after surgery No
Secondary Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) at middle term Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) from baseline to 90 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation.
Comparison between both groups (preoperative rehabilitation vs. usual).
Three months after surgery No
Secondary Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) at long term Change in self-rated quality of life (measured with WHOQOL-Bref questionnaire) from baseline to 365 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation.
Comparison between both groups (preoperative rehabilitation vs. usual).
One year after surgery No
Secondary Acute change in vestibular function Change in vestibular function (measured by means of videonystagmography) from baseline to 8 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and videonystagmographic tests include both pendular and caloric tests.
Comparison between both groups (preoperative rehabilitation vs. usual).
One week after surgery No
Secondary Change in vestibular function at short term Change in vestibular function (measured by means of videonystagmography) from baseline to 30 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and videonystagmographic tests include both pendular and caloric tests.
Comparison between both groups (preoperative rehabilitation vs. usual).
One month after surgery No
Secondary Change in vestibular function at middle term Change in vestibular function (measured by means of videonystagmography) from baseline to 90 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and videonystagmographic tests include both pendular and caloric tests.
Comparison between both groups (preoperative rehabilitation vs. usual).
Three months after surgery No
Secondary Change in vestibular function at long term Change in vestibular function (measured by means of videonystagmography) from baseline to 365 days after surgery. The baseline corresponds to the day before the preoperative rehabilitation and videonystagmographic tests include both pendular and caloric tests.
Comparison between both groups (preoperative rehabilitation vs. usual).
One year after surgery No
Secondary Preoperative change in vestibular function Change in vestibular function (measured by means of videonystagmography) from baseline to three days before surgery. The baseline corresponds to the day before the preoperative rehabilitation and videonystagmographic tests include both pendular and caloric tests.
Comparison between both groups (preoperative rehabilitation vs. usual).
From baseline to three days before surgery No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04196933 - Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma N/A
Active, not recruiting NCT00973739 - Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors Phase 2
Completed NCT04351373 - Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560 Phase 2
Active, not recruiting NCT01449604 - Stereotactic Radiation in Vestibular Schwannoma Phase 3
Completed NCT01207687 - Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2) Phase 2
Not yet recruiting NCT05567341 - Remote Ischemic Preconditioning in Vestibular Schwannoma Surgery N/A
Completed NCT02249572 - Vestibular Schwannoma - Radiosurgery or Expectation: V-REX. N/A
Terminated NCT05116878 - Enhancing Facial Nerve Function With Omega-3 After Resection of Vestibular Schwannoma N/A
Suspended NCT03095248 - Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors Phase 2
Recruiting NCT04801953 - Nimodipine in Vestibular Schwanommas Phase 2
Recruiting NCT03745560 - Intraoperative EABR for Decision Making
Recruiting NCT04859335 - Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma N/A
Recruiting NCT04128345 - Novel Multimodality Imaging for Navigation in Skull Base Surgery
Active, not recruiting NCT01199978 - Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma Phase 2
Recruiting NCT04057976 - Use of DTT to Define Facial Nerve Position in Vestibular Schwannomas N/A
Completed NCT00863122 - Concentration and Activity of Lapatinib in Vestibular Schwannomas Early Phase 1
Recruiting NCT04374305 - Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) Phase 2
Recruiting NCT03079999 - Study of Aspirin in Patients With Vestibular Schwannoma Phase 2
Recruiting NCT05786144 - Vestibular Schwannoma Organoids
Recruiting NCT03593577 - Secondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI